The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 13.4% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 42% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 107%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (4 analysts) rates it none, with a mean price target of $100.
Graham Corporation
GHM · the NYSE · USD · Market cap $1.0B · 732 employees
Graham Corporation designs and manufactures fluid, power, heat transfer, and vacuum technologies for chemical and petrochemical processing, defense, space, petroleum refining, cryogenic, and energy industries.
PASS · Titan Ethical · score 70.0At the last full screen
2026-09-16
Screened 2026-09-16 · the tape above runs as of 21:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its distribution label.
Graham Corporation holds its Distribution at $85.28. The statistical read favours the buyers, held for 56 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the buyers, held for 56 days |
| Price at the screen | $85.28 |
| Valuation | 82.80 trailing · 37.65 forward price to earnings |
| Values screen | PASS · score 70.0 |
| Beta | 1.05 |
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 6.24% | Below 33% | Interest-bearing debt is just 6.2% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 12.48% | Below 49% | Money owed to the company is 12.5% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.10% | Below 5% | Only 0.1% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value range in USD, drawn from the 2026-09-16 screen. The gold marker is the market price at the same screen. A 2.8% margin of safety to the base estimate.
Third-party analyst targets: 4 covering, consensus None. The average target sits +52% from the screen price.
Reading the gap · Our more conservative model reads it as roughly fairly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-16 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsIndustrial supplier priced well above fair value
Picture a workshop building vacuum systems for rockets and refineries. Graham Corporation does exactly that, yet the shares trade at $107.79 against a fair value of $87.53. Revenue is rising 13 percent, but a 47.9 times forward earnings multiple sits on top of 5 percent margins and 10 percent return on equity. We pass because the valuation already assumes far stronger returns than the business has delivered.
The ethical screen is clear, yet the opportunity rating is none. Unknown competitive moat and modest profitability leave little room for error at current levels. Four analysts see a median target of $130, but that optimism does not change the gap between price and our assessment of worth.
Cyclical demand in energy and defence can swing sharply, and thin margins offer scant cushion when orders slow. Any slowdown would expose how little the current price leaves for disappointment. Analysis, not advice.
| Forward P/E | 37.7xpriced for continued growth |
| Trailing P/E | 82.8xexpensive: the price assumes strong growth ahead |
| EPS, trailing | 1.03 |
| EPS, forward | 2.27 |
| Revenue growth | +28.6%strong top-line growth |
| Profit margin | 4.5%barely profitable |
| Return on equity | 7.5%a modest return on shareholder capital |
| FCF yield | -0.58% |
| Debt to equity | 3.53heavy leverage: higher risk if revenue softens |
| Current ratio | 1.23adequate liquidity, worth monitoring |
| Beta | 1.05moves a little more than the market |
| Short interest, float | 0.08% |
| 52-week range | 49.19 - 125.82 |
| Market cap | $1.0B |
| Employees | 732 |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeGHM trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 3.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 42% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 107%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (4 analysts) rates it none, with a mean price target of $100.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it A, carrying a low risk profile. Technically it is holding around 42% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 107%. Our forward projection puts the odds of a 10% gain over the next month near 43%. The street (4 analysts) rates it none, with a mean price target of $100.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
The framework reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $98.32 | -2.0% | · | $980 | -2.0% |
| 2 months | $91.09 | +5.8% | · | $1,058 | +5.8% |
| 3 months | $80.95 | +19.1% | · | $1,191 | +19.1% |
| 6 months | $64.53 | +49.3% | · | $1,493 | +49.3% |
| 1 year | $46.50 | +107.3% | · | $2,073 | +107.3% |
| 2 years | $29.34 | +228.5% | · | $3,285 | +228.5% |
| 3 years | $13.00 | +641.3% | · | $7,413 | +641.3% |
| 5 years | $14.09 | +583.9% | $0.22 | $6,855 | +585.5% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever GHM does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.